The FDA approved an extension of dosing intervals for Eylea HD in patients with diabetic macular edema and wet age-related macular degeneration, Regeneron Pharmaceuticals, Inc. announced. K.C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results